French biotech company Afyren reported first-half revenue of €1.265 million ($1.44m), up from €1.204 million ($1.37m) a year earlier, as production ramps up at its Afyren Neoxy plant.
The company completed its €11.3 million ($12.85m) acquisition of Bpifrance’s SPI fund’s 48.92% stake – which means it now has full ownership of the plant.
Already have an account? Log In
Recommended
Most Popular
Latest Magazine
Features
Why China’s new wastewater standard is only one part of a broader shift spanning environmental law
As Brussels switches on its product passport registry, fashion’s supply chain data gaps threaten a bumpy rollout
As green claims face closer regulatory scrutiny liability no longer sits solely with the brands
News
Preview of our Textile Standards & Legislation Guide
China’s strengthened rules make officials personally accountable for serious environmental damage
New process to strip reactive dyes from cotton could benefit textile-to-textile recycling
Opinion
European factory closures show costs, geography and demand decide which materials survive
Other publications from MCL News & Media
